Tg Therapeutics (TGTX) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Tg Therapeutics (TGTX) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -347.04% |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 1,378.45% |
| 10 | Tg Therapeutics | 8.05 Bn | 7.98 Bn | 171.41 Mn | 255.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 255.71% |
| Dec 31, 2025 | 209.17% |
| Sep 30, 2025 | 182.70% |
| Jun 30, 2025 | 713.87% |
| Mar 31, 2025 | 298.59% |
| Dec 31, 2024 | -71.71% |
| Sep 30, 2024 | -95.25% |
| Jun 30, 2024 | 105.42% |
| Mar 31, 2024 | 95.06% |
| Dec 31, 2023 | 171.60% |
| Sep 30, 2023 | 439.62% |
| Jun 30, 2023 | -421.96% |
| Mar 31, 2023 | -60.68% |
| Dec 31, 2022 | 60.96% |
| Sep 30, 2022 | -23.53% |
| Jun 30, 2022 | 80.08% |
| Mar 31, 2022 | 74.59% |
| Dec 31, 2021 | 61.60% |
| Sep 30, 2021 | -279,216.75% |
| Jun 30, 2021 | -753,210.87% |